Disclosed are devices and methods for collection, labeling and matching biological samples containing nucleic acid in conjunction with collecting at least one ridge and valley signature such as a fingerprint or footprint of an individual. Such devices and methods are used in forensic, human identification, paternity, tissue typing, and screening technologies to rapidly process an individual's identity, determine the identity of an individual along with the genotype profile of the individual.

The present patent of invention describes a high-resolution portable biometric reader for newborns that, according to the characteristics thereof, provides for the creation of a biometric reader for newborns (1) in a curved portable structure of electronic type and based on a frame and a comfortable handle enabling the operator to hold the reader in a single hand and arrange the capture surface area according to the newborn's position thus enabling the fingerprints of the newborn and those of the mother to be digitally captured using the frustrated total internal reflection technique with a prism as an optical system (4) having a resolution greater than 29 lp/mm (1450 ppi) over the entire capture area of more than 18?36 mm, so as to provide full optimization in the capturing procedures for fingerprint, palm-print and footprint imaging of newborn babies and the fingerprints of the respective mothers, i.e., the simultaneous registration of the fingerprints of both the baby and the mother and the subsequent inclusion in a medical register system to improve record tracking.

Disclosed is a foot vein authentication device comprising: a body part having a front surface and a rear surface and on which the foot of a user is placed on the front surface; a sensor unit arranged on any one area of the body part and formed so as to detect a vein pattern on the inside of the foot of the user; and a control unit for carrying out a user authentication procedure by comparing the vein pattern received from the sensor unit, with the pre-stored vein pattern of the user, wherein the sensor unit comprises: a light source unit for emitting infrared rays at the inside of the foot of the user; and an image acquisition unit for acquiring, as an image, the vein pattern on the inside of the foot of the user, at which the infrared rays are emitted, so as to transmit the same to the control unit.

Disclosed is a foot vein authentication device comprising: a body part having a front surface and a rear surface and on which the foot of a user is placed on the front surface; a sensor unit arranged on any one area of the body part and formed so as to detect a vein pattern on the inside of the foot of the user; and a control unit for carrying out a user authentication procedure by comparing the vein pattern received from the sensor unit, with the pre-stored vein pattern of the user, wherein the sensor unit comprises: a light source unit for emitting infrared rays at the inside of the foot of the user; and an image acquisition unit for acquiring, as an image, the vein pattern on the inside of the foot of the user, at which the infrared rays are emitted, so as to transmit the same to the control unit.

Embodiments of the present disclosure relate to the field of shoe production. There provides a smart shoe which has an identification function. The smart shoe includes an upper, a shoe sole and a foot sole print recognition sensor disposed in the shoe sole; the foot sole print recognition sensor is configured to acquire foot sole print information of a user who wears the smart shoe.

Embodiments of the present disclosure relate to the field of shoe production. There provides a smart shoe which has an identification function. The smart shoe includes an upper, a shoe sole and a foot sole print recognition sensor disposed in the shoe sole; the foot sole print recognition sensor is configured to acquire foot sole print information of a user who wears the smart shoe.

The present invention provides a secure pharmaceutical container. The secure container includes a plurality of compartments for storing pills, tablets, solutions, pastes, creams, ointments, gels, emulsions, or any other pharmaceutical product. The compartments each include a locking mechanism that is operably connected to a biometric system, such as a fingerprint scanner. The compartments become unlocked upon the fingerprint scanner reading an approved fingerprint, ensuring that only individuals approved to have access to the container are granted access.

The present invention provides a secure pharmaceutical container. The secure container includes a plurality of compartments for storing pills, tablets, solutions, pastes, creams, ointments, gels, emulsions, or any other pharmaceutical product. The compartments each include a locking mechanism that is operably connected to a biometric system, such as a fingerprint scanner. The compartments become unlocked upon the fingerprint scanner reading an approved fingerprint, ensuring that only individuals approved to have access to the container are granted access.

An assisted early screening system for Down syndrome, relating to assisted screening of Down syndrome skin prints based on a machine learning algorithm, wherein the system comprising: (a) a skin print feature input module; (b) a processing module for diagnosis of Down syndrome based on skin print, wherein the processing module performs a scoring processing on the inputted skin print features according to a predetermined evaluation criteria to obtain a risk score, and compares the risk score with a Down syndrome risk threshold, thereby obtaining an assisted screening result; and (c) an output module for assisted screening result, which is configured to output the assisted screening result. The assisted early screening system for Down syndrome can implement simple, accurate, and effective assisted early screening of Down syndrome, such that powerful assistance can be provided for postnatal early intervention for early Down syndrome patients.

An assisted early screening system for Down syndrome, relating to assisted screening of Down syndrome skin prints based on a machine learning algorithm, wherein the system comprising: (a) a skin print feature input module; (b) a processing module for diagnosis of Down syndrome based on skin print, wherein the processing module performs a scoring processing on the inputted skin print features according to a predetermined evaluation criteria to obtain a risk score, and compares the risk score with a Down syndrome risk threshold, thereby obtaining an assisted screening result; and (c) an output module for assisted screening result, which is configured to output the assisted screening result. The assisted early screening system for Down syndrome can implement simple, accurate, and effective assisted early screening of Down syndrome, such that powerful assistance can be provided for postnatal early intervention for early Down syndrome patients.